Dianthus Therapeutics, Inc. /DE/ (DNTH)

CIK 1690585 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for Dianthus Therapeutics, Inc. /DE/.

Recent SEC filings

FiledFormAccession number
Nov 4, 202610-Q0001690585-26-000040
Nov 4, 20268-K0001690585-26-000039
Oct 30, 2026SCHEDULE 13G0002100119-26-001565
Sep 18, 2026S-3ASR0001193125-26-395502
Sep 18, 202640001273351-26-000006
Sep 17, 20261440001950047-26-009619
Sep 3, 202640001992260-26-000009
Sep 1, 20261440001950047-26-008950
Aug 19, 202640001688199-26-000006
Aug 14, 2026SCHEDULE 13G/A0000919574-26-005203
Aug 14, 202640001778623-26-000009
Aug 13, 2026SCHEDULE 13G0000902219-26-000243
Aug 11, 202640001779934-26-000004
Aug 11, 202640001778623-26-000007
Aug 11, 202640001688199-26-000004
Aug 10, 20261440001950047-26-007887
Aug 10, 20261440001974158-26-000096
Aug 10, 20261440001950047-26-007911
Aug 7, 20261440001950047-26-007811
Aug 7, 20261440001950047-26-007814
Aug 7, 2026SCHEDULE 13G/A0001897612-26-000577
Aug 7, 20261440001950047-26-007793
Aug 7, 202640001669866-26-000010
Aug 7, 2026SCHEDULE 13G0001897612-26-000576
Aug 4, 202610-Q0001690585-26-000034